This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Massachusetts Institute of Technology, Georgia Tech Research Corporation, Recon Therapeutics, Inc.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2025
Title: Ho-Jun Suk: Inventor Advancing Dementia Treatment Technologies.
Introduction
Ho-Jun Suk is an inventor associated with Cambridge, Massachusetts. His work includes patent-protected approaches to dementia and Alzheimer’s disease treatment. His portfolio includes 4 patents.
Latest Patents
Suk’s listed patent work includes “Systems and Methods for Preventing, Mitigating, and/or Treating Dementia.” The disclosed devices and methods use combined auditory and visual stimulation, delivered non-invasively at frequencies of about 20 to 60 Hz, with about 40 Hz given as a specific example. The stimulation is designed to induce synchronized gamma oscillations in brain regions.
The patent description reports that combined auditory and visual stimulation, unlike either modality alone, can promote a microglia response in the medial prefrontal cortex. It also describes an extended microglia clustering response in the auditory cortex, visual cortex, and medial prefrontal cortex. These approaches are presented for treating dementia or Alzheimer’s disease.
Career Highlights
Suk’s listed affiliations include the Massachusetts Institute of Technology and Recon Therapeutics, Inc. His patent work connects research and technology development with potential therapeutic applications.
Collaborations
His listed collaborators include Anthony James Martorell and Edward Stuart Boyden. Their names are associated with the patent work described above.
Conclusion
Ho-Jun Suk’s patent portfolio focuses on non-invasive sensory stimulation approaches intended to influence brain activity and support dementia and Alzheimer’s disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile